These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1714005)

  • 41. Effect of nifedipine and verapamil on hypotensive action of clonidine in rabbits.
    Czarnecka E; Tymczyszyn W; Pietrzak B
    Pol J Pharmacol; 1998; 50(3):193-201. PubMed ID: 9861627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
    Hof RP
    Br J Pharmacol; 1983 Feb; 78(2):375-94. PubMed ID: 6831117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diltiazem and vecuronium: neuromuscular and cardiovascular effects.
    Saitoh Y; Makita K; Tanaka H
    Can J Anaesth; 1997 Jan; 44(1):99. PubMed ID: 8988833
    [No Abstract]   [Full Text] [Related]  

  • 44. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
    Griffin KA; Picken MM; Bakris GL; Bidani AK
    Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of the autonomic nervous system in the hypotensive action of calcium antagonists in rats.
    Peter EJ; Eikenburg DC; Lokhandwala MF
    Proc West Pharmacol Soc; 1983; 26():329-31. PubMed ID: 6889361
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative effects of verapamil, diltiazem and felodipine during experimental digitalis-induced arrhythmias.
    Bush LR; Evans RM; Gaul SL; D'Alonzo AJ
    Pharmacology; 1987; 34(2-3):111-20. PubMed ID: 3588655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of calcium channel blockers on sinoatrial conduction in the isolated and blood-perfused dog atrium.
    Kobayashi M; Shimotori M; Ogiwara Y; Chiba S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):72-82. PubMed ID: 3485962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of calcium blockers on the performance of left and right ventricles during acute hypoxia].
    Zhou ZN; Gu LM; Yuan F; Xiao Y
    Sheng Li Xue Bao; 1992 Jun; 44(3):237-43. PubMed ID: 1455255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
    Rowland E; McKenna WJ; Gülker H; Krikler DM
    Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of calcium channel antagonists on carotid sinus baroreflex control of arterial pressure and heart rate in anesthetized dogs.
    Rigel DF; Millard RW
    Circ Res; 1989 Feb; 64(2):276-86. PubMed ID: 2912599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord.
    Omote K; Sonoda H; Kawamata M; Iwasaki H; Namiki A
    Anesthesiology; 1993 Oct; 79(4):746-52. PubMed ID: 8214754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of calcium channel blockers in the treatment of hypertension.
    Halperin AK; Cubeddu LX
    Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651
    [No Abstract]   [Full Text] [Related]  

  • 54. Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
    Takahara A; Dohmoto H; Yoshimoto R; Sugiyama A; Hashimoto K
    Eur J Pharmacol; 2001 Feb; 413(1):101-8. PubMed ID: 11173068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of orally administered HNS-32, an originally synthesized azulene-1-carboxamidine derivative, assessed in the in vivo rat model.
    Saitoh M; Sugiyama A; Nakazawa T; Hashimoto K
    Jpn J Pharmacol; 2002 Jul; 89(3):316-9. PubMed ID: 12184739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the mechanism of the anti-hypertensive effect of Ca++-blockers.
    Marmo E
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):59-64. PubMed ID: 3952371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuation of cardiovascular responses to tracheal extubation: verapamil versus diltiazem.
    Mikawa K; Nishina K; Maekawa N; Obara H
    Anesth Analg; 1996 Jun; 82(6):1205-10. PubMed ID: 8638792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium channel blockers and the CVS reflex responses during lower body suction.
    Dikshit MB; Lavania AK; Devdikar AR; Prasad BA; Jog NV; Ganguly SS
    Indian J Physiol Pharmacol; 1991 Oct; 35(4):232-6. PubMed ID: 1812095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.